Blood Pressure Home > Tekamlo and Pregnancy
Based on the results of animal studies, the FDA considers Tekamlo (aliskiren/amlodipine) a pregnancy Category D medication. This means that the risk of problems the drug presents to the fetus is typically greater than any benefit the woman might gain from taking it. All other alternatives should be explored first since Tekamlo can cause serious birth defects and even fetal death.
Can Pregnant Women Take Tekamlo?Tekamlo™ (aliskiren/amlodipine) is a prescription medication approved to treat high blood pressure (hypertension). Pregnant women should not take Tekamlo, due to possible problems seen with medications similar to the aliskiren component of it.
What Is Pregnancy Category D?The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category D is given to medications that have been shown to present a risk to the fetus in studies of pregnant women but may still offer benefits that outweigh the risks the drug presents.
The Effects of Tekamlo on the Renin-Angiotensin SystemMany blood pressure medications (including Tekamlo) work by acting on the renin-angiotensin systems. Such medications should be avoided during pregnancy in almost all situations, as they have been shown to cause serious problems.
- Low blood pressure of the fetus or newborn
- Skull problems
- Severe kidney problems
- Fetal and newborn death.